1.
Lebwohl M, Armstrong AW, Merola JF, Gottlieb AB, Davis L, Gomez B, Wiegratz S, Cross N, Strober B. Bimekizumab efficacy through one year in patients with moderate to severe plaque psoriasis in subgroups defined by prior biologic treatment: Pooled results from four phase 3/3b trials . J of Skin [Internet]. 2022Nov.16 [cited 2024Mar.29];6(6):s64. Available from: https://jofskin.org/index.php/skin/article/view/1819